Is Mediwound Stock a Good Investment?

Mediwound Investment Advice

MDWD

To provide specific investment advice or recommendations on Mediwound stock, we recommend investors consider the following general factors when evaluating Mediwound. This will help you to make an informed decision on whether to include Mediwound in one of your diversified portfolios:

Examine Mediwound's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Mediwound's leadership team and their track record. Good management can help Mediwound navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Mediwound's business and its evolving consumer preferences.
Compare Mediwound's performance and market position to its competitors. Analyze how Mediwound is positioned in terms of product offerings, innovation, and market share.
Check if Mediwound pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Mediwound's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Mediwound stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Mediwound is a good investment.

Sell

Buy

Strong Hold

Our advice module complements current analysts and expert consensus on Mediwound. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Mediwound is not overpriced, please verify all Mediwound fundamentals, including its ebitda, cash flow from operations, and the relationship between the price to book and total debt . Given that Mediwound has a price to earning of 16.58 X, we recommend you to check Mediwound market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Market Performance	OK	Details
Volatility	Very steady	Details
Hype Condition	Under hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Follows the market closely	Details
Investor Sentiment	Interested	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Poor	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Mediwound Stock

Researching Mediwound's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 18.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.05. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022.

To determine if Mediwound is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Mediwound's research are outlined below:

	The company reported the previous year's revenue of 20.22 M. Net Loss for the year was (30.22 M) with profit before overhead, payroll, taxes, and interest of 2.77 M.
	Mediwound currently holds about 10.41 M in cash with (13.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
	Mediwound has a poor financial position based on the latest SEC disclosures
	Roughly 18.0% of the company outstanding shares are owned by corporate insiders
	Latest headline from news.google.com: Is MediWound Ltd. a good long term investment - Unmatched profit potential - Autocar Professional

Mediwound uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Mediwound. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mediwound's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	21st of March 2024 Upcoming Quarterly Report	View
	4th of June 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	21st of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Mediwound's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Mediwound's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-03-21	2023-12-31	-0.23	-0.19	0.04	17
2022-05-17	2022-03-31	-0.76	-0.84	-0.08	10
2021-05-05	2021-03-31	-0.78	-0.7	0.08	10
2023-05-30	2023-03-31	-0.3	-0.44	-0.14	46
2022-08-09	2022-06-30	-0.68	-0.84	-0.16	23
2020-11-10	2020-09-30	-0.67	-0.49	0.18	26
2020-02-25	2019-12-31	-0.73	-0.91	-0.18	24
2023-11-21	2023-09-30	-0.44	-0.24	0.2	45

Know Mediwound's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Mediwound is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mediwound backward and forwards among themselves. Mediwound's institutional investor refers to the entity that pools money to purchase Mediwound's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
State Street Corp	2025-03-31	72.1 K
Sargent Investment Group, Llc	2025-03-31	68.7 K
Ubs Group Ag	2025-03-31	67.8 K
Dafna Capital Management Llc	2025-03-31	64.5 K
Vanguard Group Inc	2025-03-31	61.5 K
Legato Capital Management Llc	2025-03-31	43.2 K
Morgan Stanley - Brokerage Accounts	2025-03-31	36.6 K
Meitav Dash Investments Ltd	2025-03-31	31.5 K
Charles Schwab Investment Management Inc	2025-03-31	22.5 K
Investors Finance Co Plc	2025-03-31	872.1 K
Yelin Lapidot Holdings Management Ltd	2025-03-31	858 K

Note, although Mediwound's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mediwound's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 216.91 M.

Market Cap

185.25 Million

Mediwound's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.41)	(0.43)
Return On Capital Employed	(0.41)	(0.43)
Return On Assets	(0.41)	(0.43)
Return On Equity	(0.97)	(1.02)

The company has Profit Margin (PM) of (1.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.32) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.32.

Determining Mediwound's profitability involves analyzing its financial statements and using various financial metrics to determine if Mediwound is a good buy. For example, gross profit margin measures Mediwound's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Mediwound's profitability and make more informed investment decisions.

Please note, the presentation of Mediwound's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mediwound's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mediwound's management manipulating its earnings.

Evaluate Mediwound's management efficiency

Mediwound has return on total asset (ROA) of (0.1988) % which means that it has lost $0.1988 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7792) %, meaning that it created substantial loss on money invested by shareholders. Mediwound's management efficiency ratios could be used to measure how well Mediwound manages its routine affairs as well as how well it operates its assets and liabilities. As of July 23, 2025, Return On Tangible Assets is expected to decline to -0.43. In addition to that, Return On Capital Employed is expected to decline to -0.43. At present, Mediwound's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.29, whereas Non Currrent Assets Other are forecasted to decline to about 310.2 K.

	Last Reported	Projected for Next Year
Book Value Per Share	3.13	3.59
Tangible Book Value Per Share	3.12	3.28
Enterprise Value Over EBITDA	(6.21)	(6.52)
Price Book Value Ratio	5.69	6.09
Enterprise Value Multiple	(6.21)	(6.52)
Price Fair Value	5.69	6.09
Enterprise Value	174.6 M	149 M

Effective management at Mediwound has been a driving force behind its market achievements. We assess the correlation between management practices and financial success to determine the stock's value.

Beta

0.302

Basic technical analysis of Mediwound Stock

As of the 23rd of July, Mediwound secures the Risk Adjusted Performance of 0.147, downside deviation of 2.14, and Mean Deviation of 1.75. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mediwound, as well as the relationship between them. Please verify Mediwound treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mediwound is priced some-what accurately, providing market reflects its recent price of 20.83 per share. Given that Mediwound has jensen alpha of 0.2683, we recommend you to check Mediwound's last-minute market performance to make sure the company can sustain itself at a future point.

Mediwound's Outstanding Corporate Bonds

Mediwound issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mediwound uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mediwound bonds can be classified according to their maturity, which is the date when Mediwound has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	BNP Paribas FRN Corp Bond USF1R15XK367	View
	Morgan Stanley 3971 Corp Bond US61744YAL20	View
	Valero Energy Partners Corp Bond US91914JAA07	View

View All Mediwound Corporate Bonds

Understand Mediwound's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Mediwound's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.147
	Market Risk Adjusted Performance	0.638
	Mean Deviation	1.75
	Semi Deviation	1.7
	Downside Deviation	2.14
	Coefficient Of Variation	641.15
	Standard Deviation	2.41
	Variance	5.83
	Information Ratio	0.0821
	Jensen Alpha	0.2683
	Total Risk Alpha	(0.08)
	Sortino Ratio	0.0927
	Treynor Ratio	0.628
	Maximum Drawdown	11.84
	Value At Risk	(3.15)
	Potential Upside	4.97
	Downside Variance	4.57
	Semi Variance	2.88
	Expected Short fall	(1.95)
	Skewness	0.528
	Kurtosis	0.9312

	Risk Adjusted Performance	0.147
	Market Risk Adjusted Performance	0.638
	Mean Deviation	1.75
	Semi Deviation	1.7
	Downside Deviation	2.14
	Coefficient Of Variation	641.15
	Standard Deviation	2.41
	Variance	5.83
	Information Ratio	0.0821
	Jensen Alpha	0.2683
	Total Risk Alpha	(0.08)
	Sortino Ratio	0.0927
	Treynor Ratio	0.628
	Maximum Drawdown	11.84
	Value At Risk	(3.15)
	Potential Upside	4.97
	Downside Variance	4.57
	Semi Variance	2.88
	Expected Short fall	(1.95)
	Skewness	0.528
	Kurtosis	0.9312

Consider Mediwound's intraday indicators

Mediwound intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mediwound stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0163
	Daily Balance Of Power	1.0
	Rate Of Daily Change	1.02
	Day Median Price	20.66
	Day Typical Price	20.72
	Market Facilitation Index	0.34
	Price Action Indicator	0.34
	Period Momentum Indicator	0.34
	Relative Strength Index	61.23

Mediwound Corporate Filings

6K	21st of May 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
	12th of May 2025 Other Reports	View Verify
	28th of March 2025 Other Reports	View Verify
13A	23rd of October 2024 An amended filing to the original Schedule 13G	View Verify

Mediwound time-series forecasting models is one of many Mediwound's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mediwound's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mediwound Stock media impact

There is far too much social signal, news, headlines, and media speculation about Mediwound that are available to investors today. This information is accessible both publicly - through Mediwound's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Mediwound-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.

A primary focus of Mediwound news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mediwound relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mediwound's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mediwound alpha.

Mediwound Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Mediwound can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Mediwound Maximum Pain Price Across September 19th 2025 Option Contracts

Mediwound's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Mediwound close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Mediwound's options.

Mediwound Corporate Management

Hagit Mashiach	VP Resources	Profile
CPA CPA	Ex Director	Profile
Hani Luxenburg	Chief Officer	Profile
Pr MD	CoFounder Director	Profile
Ety MBA	Chief Officer	Profile
Ofer BSc	Chief Officer	Profile

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports: